Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
193. Dialysis cysts?
|
a. Cortical and medullary cysts resulting from long-standing dialysis.
|
|
194. Simple cysts of kidney?
|
a. Benign, common (>40% of elderly)
b. Incidental finding. c. This, nonenhancing, cortical, fluid filled. |
|
195. Medullary cystic disease?
|
a. Medullary cysts sometimes lead to fibrosis and progressive renal insufficiency with urinary concentrating defects.
b. Ultrasound shows SMALL kidney. c. Poor prognosis. |
|
196. Mannitol MOA?
|
a. Osmotic diuretic
b. ↑ tubular fluid osmolarity, producing ↑ urine flow. |
|
197. Clinical use of Mannitol?
|
a. Shock
b. Drug overdose c. ↑ ICP or intraocular pressure |
|
198. Mannitol toxicity?
|
a. Pulmonary oedema
b. Dehydration |
|
199. When is mannitol contraindicated?
|
a. Anuria
b. CHF. |
|
200. MOA of Acetazolamide?
|
a. Carbonic anhydrase inhibitor.
b. Causes self-limited NaHCO3 diureses and reduction in total-body HCO3 stores. |
|
201. Clinical use of acetazolamide?
|
a. Glaucoma
b. Urinary alkalinization c. Metabolic alkalosis d. Altitude sickness. |
|
202. Toxicity of acetazolamide?
|
a. Hyperchloremic metabolic acidosis
b. Neuropathy c. NH3 toxicity d. Sulfa allergy. e. “ACIDazolamide causes ACIDOSIS”. |
|
203. Furosemide MOA?
|
a. Sulfonamide loop diuretic.
b. Inhibits cotransport of Na-K-2Cl of thick ascending limb. c. Abolishes hypertonicity of medulla, preventing concentration of urine. d. ↑ Ca2+ excretion. Loops Lose Calcium. |
|
204. Clinical uses of furosemide?
|
a. Oedematous states (CHF, cirrhosis, nephrotic syndrome, pulmonary oedema)
b. HTN c. Hypercalcemia |
|
205. Toxicity of Furosemide?
|
a. Oto and renal (interstitial nephritis- bc it’s a sulfonamide derivative)
b. Hypokalaemia c. Allergy (sulfa)!!!! d. Gout e. Dehydration |
|
206. Ethacrynic acid MOA?
|
a. Phenoxyacetic acid derivative (NOT a sulfonamide).
b. Essentially same MOA as furosemide. |
|
207. Clinical use of Ethacrynic acid?
|
a. Diuresis in pts allergic to sulfa drugs.
|
|
208. Tox of ethacrynic acid?
|
a. Similar to furosemide but can be used in pts w/hyperuricemia and acute gout (never used to treat gout).
|
|
209. HCTZ MOA?
|
a. Inhibits NaCl reabsorption in early distal tubule, reducing diluting capacity of the nephron.
b. ↓ Ca excretion (so retains calcium). |
|
210. Clinical use of HCTZ?
|
a. HTN
b. CHF c. Idiopathic hypercalciuria d. Nephrogenic diabetes insipidus. |
|
211. Tox of HCTZ?
|
a. Hypokalemic metabolic alkalosis
b. Hyponatremia c. Hyperglycemia d. Hyperlipidemia e. Hyperuricemia f. Hypercalcemia. g. Sulfa allergy. |
|
212. K+ sparing diuretics listed (4)?
|
1. Spironolactone
2. Triamterene 3. Amiloride 4. Eplerone |
|
213. MOA of Spironolactone?
|
a. Competitive aldosterone receptor antagonist in the cortical collecting tubule.
|
|
214. How does the MOA of Triamterene and amiloride differ from Spirinolactone?
|
a. They act at the same part of the tubule by blocking Na channels in the CCT.
|
|
215. Clinical use of spironolactone?
|
a. Hyperaldosteronism
b. K+ depletion c. CHF |
|
216. Tox of Spironolactone?
|
a. Hyperkalemia- arrhythmias
b. Gynecomastia c. Impotence |
|
217. Effect of all diuretics on Urine NaCl?
|
a. All diuretics ↑ urine NaCl.
b. Serum NaCl may ↓ as a result. |
|
218. Effect of all diuretics except for K-sparing on urine K+?
|
a. All ↑ urine K (save for K sparing).
b. Serum K may ↓ as a result. |
|
219. Which diuretics ↓ blood pH (causing acidemia)?
|
a. Carbonic anhydrase inhibitors- HCO3- reabsorption.
b. K+ sparing aldosterone blockade prevents K+ and H+ secretion. c. Additionally, hyperkalemia leads to K+ entering all cells (via H+/K+ exchanger in exchange for H+ exiting cells. |
|
220. Which diuretics ↑ pH (causing alkalemia)?
|
a. Loop diuretics and thiazides cause alkalemia through several mechanisms:
1. Volume contraction: ↑ ATII-> ↑ Na/H+ exchanger in proximal tubule -> ↑ HCO3 (“contraction alkalosis”. 2. K+ loss leads to K+ exiting all cells (via H+/K+ exchanger) in exchange for H+ entering cells. 3. In low K+ state, H+ (rather than k+) is exchanged for Na in cortical collecting tubule, leading to alkalosis and “paradoxical aciduria”. |
|
221. How do Loops ↑ urine Ca?
|
a. Abolish lumen-positive potential in thick ascending limb-> ↓ paracellular Ca2+ reabsorption -> hypocalcemia and ↑ urinary Ca2+.
|
|
222. How do thiazides ↓ urine Ca?
|
a. Volume depletion -> ↑up-regulation of sodium reabsorption -> enhanced paracellular Ca reabsorption in proximal tubule and LOH.
b. Thiazides also block luminal Na/Cl cotransport in distal tubule ->↑ Na+ gradient -> ↑ interstitial Na/Ca exchange -> hypercalcemia. |
|
223. MOA of ACE inhibitors?
|
a. Inhibit ACE, reducing levels of AG II and PREVENTING INACIVATION of bradykinin, a potent vasodilator.
b. Renin release is ↑ due to loss of feedback inhibition. |
|
224. Clinical uses of ACE inhibitors?
|
a. HTN
b. CHF c. Diabetic real disease. |
|
225. Toxicity of ACE inhibitors?
|
a. Dry cough
b. Angioedema c. Proteinuria d. Taste changes e. Hypotension f. Pregnancy problems (fetal renal damage) g. Rash h. Increased renin i. Lower angiotensin II. j. Hyperkalemia! |
|
226. When should you avoid ACE inhibitors?
|
a. Pregnancy
b. Hyperkalemia c. Bilateral renal artery stenosis bc ACE inhibitors significantly ↓ GFR by preventing constriction of efferent arterioles. |
|
227. Complete
|
227. Complete
|